Deferasirox IH is a medication used to treat iron overload in patients with hereditary hemochromatosis, offering a targeted solution for managing excessive iron levels. By effectively chelating iron, Deferasirox IH helps restore balance and prevent potential complications associated with iron accumulation.
| Specification | Details |
|---|---|
| Medication Name | Deferasirox IH |
| Indication | Treatment of iron overload in hereditary hemochromatosis |
| Mechanism of Action | Chelation of iron |
| Dosage Form | Oral tablets |
| Strength | Varies (e.g., 125 mg, 250 mg, 500 mg) |
| Administration | Taken orally with water or juice, preferably on an empty stomach |
| Frequency of Dosage | Typically once daily |
| Duration of Treatment | Individualized based on iron levels and response to therapy |
| Monitoring Parameters | Regular assessment of serum ferritin levels, liver function tests, and renal function |
| Adverse Effects | Common: Nausea, vomiting, abdominal pain, skin rash |
| Serious: Renal impairment, liver toxicity | |
| Contraindications | Hypersensitivity to Deferasirox, severe renal impairment, advanced liver disease |
Copyright © 2023. All rights reserved. Design By Techno Mantra
Copyright © 2024 – All rights reserved. Design By Technomantra India / Technomantra Global / Technomantra us / Technomantra Canada Technomantra local / Technomantra Australia